MORRONE, DORALISA
 Distribuzione geografica
Continente #
NA - Nord America 4.669
AS - Asia 2.037
EU - Europa 1.855
SA - Sud America 369
AF - Africa 120
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 2
Totale 9.061
Nazione #
US - Stati Uniti d'America 4.568
CN - Cina 590
SG - Singapore 590
IT - Italia 559
HK - Hong Kong 475
SE - Svezia 393
BR - Brasile 312
DE - Germania 287
BG - Bulgaria 154
VN - Vietnam 134
FI - Finlandia 106
RU - Federazione Russa 94
GB - Regno Unito 82
TR - Turchia 74
CA - Canada 71
CI - Costa d'Avorio 46
FR - Francia 42
AT - Austria 34
IN - India 34
AR - Argentina 22
NG - Nigeria 20
KR - Corea 19
MX - Messico 18
JP - Giappone 17
BD - Bangladesh 16
UA - Ucraina 15
ZA - Sudafrica 15
ID - Indonesia 13
SN - Senegal 12
EC - Ecuador 11
PL - Polonia 11
SA - Arabia Saudita 11
BE - Belgio 10
CO - Colombia 10
CZ - Repubblica Ceca 10
IQ - Iraq 10
ES - Italia 8
MA - Marocco 8
NL - Olanda 8
CH - Svizzera 6
GR - Grecia 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
EG - Egitto 5
IE - Irlanda 5
TW - Taiwan 5
AZ - Azerbaigian 4
KZ - Kazakistan 4
MY - Malesia 4
NZ - Nuova Zelanda 4
PH - Filippine 4
UZ - Uzbekistan 4
BY - Bielorussia 3
DK - Danimarca 3
DZ - Algeria 3
ET - Etiopia 3
HN - Honduras 3
HU - Ungheria 3
IR - Iran 3
JO - Giordania 3
LK - Sri Lanka 3
PK - Pakistan 3
RO - Romania 3
RS - Serbia 3
VE - Venezuela 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CL - Cile 2
DO - Repubblica Dominicana 2
EU - Europa 2
GE - Georgia 2
HR - Croazia 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
LT - Lituania 2
LU - Lussemburgo 2
PY - Paraguay 2
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BJ - Benin 1
BW - Botswana 1
CD - Congo 1
CR - Costa Rica 1
GT - Guatemala 1
LV - Lettonia 1
ML - Mali 1
MU - Mauritius 1
NP - Nepal 1
PA - Panama 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 9.061
Città #
Ashburn 538
Hong Kong 464
Woodbridge 394
Santa Clara 380
Dallas 376
Fairfield 345
Houston 300
Singapore 278
Chandler 274
Ann Arbor 252
Shanghai 188
Seattle 162
Munich 158
Sofia 154
Serra 148
Wilmington 135
Cambridge 131
New York 126
Beijing 111
Milan 86
Princeton 83
Boardman 80
Los Angeles 71
Lawrence 67
Florence 55
Medford 55
Helsinki 54
Pisa 47
Abidjan 46
Dearborn 41
Ottawa 37
Buffalo 34
Des Moines 34
Izmir 34
London 34
Dong Ket 32
São Paulo 32
Chicago 29
Istanbul 29
Frankfurt am Main 27
Hefei 26
Redondo Beach 26
Ho Chi Minh City 25
Vienna 25
Nanjing 23
San Diego 20
Rome 19
Düsseldorf 18
Lagos 18
Seoul 16
Hanoi 15
Turku 15
Jacksonville 14
Ogden 14
Tokyo 14
Dakar 12
Fuzhou 12
Guangzhou 12
Lucca 12
San Francisco 12
Lancaster 11
Nuremberg 11
Jiaxing 10
Redwood City 10
Shenyang 10
Toronto 10
Brussels 9
Mexico City 9
Warsaw 9
Beauharnois 8
Council Bluffs 8
Johannesburg 8
Mcallen 8
Nanchang 8
Cascina 7
Charlotte 7
Curitiba 7
Indiana 7
Norwalk 7
Phoenix 7
Quanzhou 7
Stockholm 7
Wuhan 7
Changsha 6
Changzhou 6
Falls Church 6
Livorno 6
Porto Alegre 6
Quito 6
Boston 5
Brasília 5
Bremen 5
Capannori 5
Dhaka 5
Elk Grove Village 5
Hebei 5
Jeddah 5
Jyväskylä 5
Kunming 5
Lima 5
Totale 6.552
Nome #
Influence of depression and anxiety on circulating endothelial progenitor cells in patients with acute coronary syndromes 277
Arterial hypertension and atrial fibrillation: standard and advanced echocardiography from diagnosis to prognostication 218
Role of circulating endothelial progenitor cells in the reparative mechanisms of stable ischemic myocardium 217
Pharmacological Agents Targeting Myocardial Metabolism for the Management of Chronic Stable Angina : an Update 189
Obstructive coronary atherosclerosis and ischemic heart disease: An elusive link! 187
Influence of depression and anxiety on circulating endothelial progenitor cells in patients with acute coronary syndromes 186
Circulating endothelial progenitor cells are actively involved in the reparative mechanisms of stable ischemic myocardium 183
Trimetazidine 179
Pharmacological approaches to coronary microvascular dysfunction 170
Prognostic value of cardiac power output to left ventricular mass in patients with left ventricular dysfunction and dobutamine stress echo negative by wall motion criteria 167
Stress Testing After Complete and Successful Coronary Revascularization 160
Determination of volatile organic compounds in human breath for monitoring heart failure patients 160
Resting heart rate is an independent predictor of left ventricular diastolic dysfunction in obese patients with or without arterial hypertension 156
Myocardial protection during PCI in STEMI : strategy reperfusion effects in acute MI patients (stream study) 151
Trimetazidine and Other Metabolic Modifiers 148
Feasibility and functional correlates of left atrial volume changes during stress echocardiography in chronic coronary syndromes 146
Appropriateness of use criteria in echocardiography: an Italian experience 142
Endothelial progenitor cells: An appraisal of relevant data from bench to bedside 142
The second law of thermodynamics and the heart 137
Pre-PCI angina post-PCI ischaemia: tales of ordinary madness 136
Sex-related differences in chronic heart failure 135
Lung Ultrasound and Pulmonary Congestion During Stress Echocardiography 135
Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response : a pooled analysis of over 21,000 subjects from 27 clinical trials 131
Trials in ischemic heart disease do not represent the ischemic universe 130
Organization and Activity of Italian Echocardiographic Laboratories: A Survey of the Italian Society of Echocardiography and Cardiovascular Imaging 124
Ultrasound assessment of left ventricular force-frequency relationship to risk stratify patients with advanced chronic systolic heart failure 124
Safety profile of statins alone or combined with ezetimibe : a pooled analysis of 27 studies including over 22,000 patients treated for 6-24 weeks 124
Antianginal Therapy for Stable Ischemic Heart Disease 124
Interventional cardiology : Cost-effectiveness of PCI guided by fractional flow reserve 124
Prediction of post percutaneous coronary intervention myocardial ischaemia 122
The central role of invasive functional coronary assessment for patients with ischemic heart disease 122
Do clinical trials in ischemic heart disease meet the needs of those with ischemia? 120
Postconditioning 118
Reply letter to Dr. Xu et al. on role of circulating endothelial progenitor cells in the reparative mechanisms of stable ischemic myocardium 118
Higher 30-day readmission rate for suspicion of ACS : effect of kidney function 117
A narrative overview: Have clinical trials of PCI vs medical therapy addressed the right question? 113
Controversies in fractional flow reserve 110
Feasibility and value of two-dimensional volumetric stress echocardiography 110
Interactions between coronary stenoses and microcirculation 108
The importance of integrated left atrial evaluation: From hypertension to heart failure with preserved ejection fraction 108
Resistant hypertension: an overview 106
The Role of Nitrates in the Management of Stable Ischemic Heart Disease: A Review of the Current Evidence and Guidelines 104
null 102
Hemodynamic heterogeneity of reduced cardiac reserve unmasked by volumetric exercise echocardiography 101
Perspectives in noninvasive imaging for chronic coronary syndromes 100
Prognostic value of stress echocardiography assessed by the ABCDE protocol 100
Long-term follow-up of elective chronic total coronary occlusion angioplasty: Analysis from the U.K. central cardiac audit database 96
The new clinical standard of integrated quadruple stress echocardiography with ABCD protocol 94
null 93
Myocardial ischemia as a multifactorial: Disease: What is new? 92
Casual diagnosis of abdominal aorta aneurysm during transthoracic echocardiographic test: Clinical case and literature review 92
Myocardial ischemia: From disease to syndrome 92
Stress echo 2030: The novel ABCDE-(FGLPR) protocol to define the future of imaging 91
Pancreatitis-associated Myocarditis: Systematic Review and Meta-analysis of a Deadly Duo 89
null 89
Role of RAAS inhibition in preventing left ventricular remodeling in patients post myocardial infarction 89
Reshaping of italian echocardiographic laboratories activities during the second wave of covid-19 pandemic and expectations for the post-pandemic era 89
Left atrial volume changes during exercise stress echocardiography in heart failure and hypertrophic cardiomyopathy 88
SAFETY OF NOVEL ORAL ANTICOAGULANTS COMPARED TO VITAMIN K ANTAGONISTS IN THE TREATMENT OF VENOUS THROMBOEMBOLISM: A SYSTEMATIC REVIEW AND META-ANALYSIS 86
The ESC ACCA EAPCI EORP acute coronary syndrome ST-elevation myocardial infarction registry 86
Efforts to decrase the door to balloon time might increase the incidence of unnecessary emergency cardiac catheterization and delay appropriate care 85
Radiation Exposure is Incresead Through the Last Ten Years 84
Echocardiographic assessment of coronary microvascular dysfunction: Basic concepts, technical aspects, and clinical settings 81
Bleeding risk score: limits and practicability 81
Sex-related differences in ventricular remodeling after myocardial infarction 79
Therapy against ischemic injury 78
null 75
Microvascular function/dysfunction downstream a coronary stenosis 75
Diagnostic approach for coronary microvascular dysfunction in patients with chest pain and no obstructive coronary artery disease 73
Mortality Prediction of the CHA2DS2-VASc Score, the HAS-BLED Score, and Their Combination in Anticoagulated Patients with Atrial Fibrillation 69
Ivabradine in Cardiovascular Disease Management Revisited: a Review 69
Acute pulmonary embolism: Focus on the clinical picture 67
null 64
Integrated quadruple stress echocardiography 62
HIT initiative: Discussion with the seniors 61
Myocardial infarction with nonobstructive coronary arteries: from pathophysiology to therapeutic strategies 59
Trials in ischemic heart disease do not represent the ishemic universe 57
Persistent angina: the Araba Phoenix of cardiology 54
Pulmonary Congestion During Exercise Stress Echocardiography in Ischemic and Heart Failure Patients 53
Clinical outcomes of patients with coronary microvascular dysfunction in absence of obstructive coronary atherosclerosis 41
In-stent restenosis after percutaneous coronary intervention: emerging knowledge on biological pathways 41
Right ventricular dysfunction is associated with chronic kidney disease and predicts survival in patients with chronic systolic heart failure. 41
Myocardial 123I-metaiodobenzylguanidine imaging in hypertension and left ventricular hypertrophy 40
Totale 9.236
Categoria #
all - tutte 28.942
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.942


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021294 0 0 0 0 48 14 9 43 29 49 23 79
2021/2022767 8 22 22 38 142 109 34 25 46 34 64 223
2022/20231.001 163 161 84 33 111 113 7 84 156 7 55 27
2023/2024697 44 67 77 43 87 153 26 36 13 22 37 92
2024/20252.625 22 85 42 136 262 311 279 118 326 336 233 475
2025/20261.451 233 332 453 321 112 0 0 0 0 0 0 0
Totale 9.236